<DOC>
	<DOCNO>NCT00000412</DOCNO>
	<brief_summary>During first year heart transplant , people often rapidly lose bone spine hip . About 35 percent people receive heart transplant suffer broken bone first year transplantation . This study compare safety effectiveness drug alendronate ( Fosamax ) active form vitamin D ( calcitriol ) prevent bone loss spine hip heart transplant . In study , people successful heart transplant receive either active alendronate `` dummy pill '' instead calcitriol , active calcitriol dummy pill instead alendronate first year transplant , start within 1 month transplant surgery . We measure bone density hip spine start study 6 12 month , also check broken bone spine . This research lead way prevent cripple form osteoporosis .</brief_summary>
	<brief_title>Osteoporosis Prevention After Heart Transplant</brief_title>
	<detailed_description>We enroll patient undergone cardiac transplantation randomize , double-blind , 12-month study efficacy safety calcitriol ( Rocaltrol ) alendronate sodium ( Fosamax ) prevention bone loss transplantation . We give participant standard pre- post-transplantation management immunosuppressive therapy , three tablet calcium citrate ( Citracal + D , contain 315 mg elemental calcium 200 IU vitamin D ) , multivitamin provide 400 unit vitamin D daily . We randomize participant one two active treatment group within 1 month transplantation . We give Group A active alendronate ( 10 mg/day ) placebo calcitriol . We give Group B placebo alendronate active calcitriol ( 0.25 microgram BID ) . The primary efficacy endpoint change spine bone mineral density ( BMD ) first 6 month transplantation . The secondary efficacy endpoint change hip BMD first year transplantation . We also monitor incidence vertebral fracture . We invite eligible subject participate study . We offer patient elect participate therapeutic trial opportunity serial BMD measurement interval treat subject follow untreated control . We continue recruitment randomize total 146 cardiac transplant recipient . We perform bone densitometry randomization ( unless perform within previous month ) 6 12 month . We obtain radiographs ( x-rays ) randomization repeat 12 month detect undiagnosed vertebral fracture .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Cardiac transplantation Active peptic ulcer disease , gastrectomy , inflammatory bowel disease , malignancy , Paget 's disease bone , osteogenesis imperfecta , multiple myeloma , primary hyperparathyroidism , rheumatoid arthritis , Cushing 's syndrome , thyrotoxicosis Suppressive dose thyroid hormone , anticonvulsant drug , past bisphosphonate therapy , current calcitonin therapy , fluoride therapy Cirrhosis , inflammatory liver disease , nephrolithiasis Serum creatinine &gt; 2.5 mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Heart transplant</keyword>
	<keyword>Bone fracture</keyword>
	<keyword>Bone density</keyword>
	<keyword>Dual energy x-ray absorptiometry</keyword>
</DOC>